The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.

Name: The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.
Author: Jia, Jun

The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer. — المؤلف: Jia, Jun — Disease markers 20190612

المؤلف: Jia, Jun
النشر: Disease markers 20190612
الوصف: 6812045 p.
الموضوعات: Aged؛ Antineoplastic Agents؛ Antineoplastic Combined Chemotherapy Protocols؛ CA-125 Antigen؛ CA-19-9 Antigen؛ Camptothecin؛ Cetuximab؛ Colorectal Neoplasms